- Tytuł:
- Fluorouracil and dose-dense adjuvant chemotherapy in patients with early-stage breast cancer (GIM2): end-of-study results from a randomised, phase 3 trial
- Autorzy:
- Źródło:
- In The Lancet Oncology December 2022 23(12):1571-1582
Czasopismo naukowe